Skip to main content
Top

Current Rheumatology Reports

Issue 3/2021

Content (7 Articles)

Glucocorticoid Vasculitis (C Dejaco & C Duftner, Section Editors)

Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis

Paride Fenaroli, Federica Maritati, Augusto Vaglio

Giant Cell Arteritis Vasculitis (C Dejaco and C Duftner, Section Editors)

Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides

Enrico Tombetti, Elvis Hysa, Justin C. Mason, Marco A. Cimmino, Dario Camellino

Vasculitis Vasculitis (C Dejaco and C Duftner, Section Editors)

Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa

Alojzija Hočevar, Matija Tomšič, Katja Perdan Pirkmajer

Tendinopathy Osteoarthritis (M Goldring and T Griffin, Section Editors)

Metabolic Regulation of Tendon Inflammation and Healing Following Injury

Jessica E. Ackerman, Katherine T. Best, Samantha N. Muscat, Alayna E. Loiselle

Streptococci Reactive Arthritis (H Zeidler, Section Editor)

Update on Post-Streptococcal Reactive Arthritis: Narrative Review of a Forgotten Disease

Sakir Ahmed, Prasanta Padhan, Ramnath Misra, Debashish Danda

Systemic Lupus Erythematosus Systemic Lupus Erythematosus (G Tsokos, Section Editor)

A Review of Complement Activation in SLE

Arthur Weinstein, Roberta V. Alexander, Debra J. Zack

Open Access Systemic Lupus Erythematosus Systemic Lupus Erythematosus (G Tsokos, Section Editor)

Systemic Lupus Erythematosus in Children and Young People

A. Charras, E. Smith, C.M. Hedrich

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine